11:00 | 09.04.2010
Precision BioSciences Inc. Announces Successful Collaboration Results and Extension of Partnership with Bayer CropScience
Precision BioSciences Inc., announced today that Bayer CropScience and
Precision BioSciences have successfully modified plant genomes using
Precision’s Directed Nuclease EditorTM (DNE) technology.
During the initial research phase of the partnership, scientists at
Bayer CropScience used a pair of engineered meganucleases produced by
Precision to target the insertion and removal of DNA at two
pre-determined locations in a plant genome.
Precision’s DNE technology, which is based on the rational production of
“custom” DNA-cleaving enzymes called “meganucleases,” enables crop
researchers to delete, insert, or otherwise modify genes at user-defined
endogenous sites within plant genomes. By facilitating the direct
introduction of favorable traits into plant species, the technology can
streamline product development and reduce the time it takes to get a
product to market.
Bayer CropScience has now elected to extend its research and commercial
partnership with Precision BioSciences. Under this extended agreement,
Precision BioSciences will be working with Bayer CropScience to develop
additional DNE-engineered enzymes for use across the company’s crop
platforms.
About Precision BioSciences
Precision’s mission is to utilize its engineered endonuclease technology
to become the world leader in the field of genomic molecular biology.
Precision’s proprietary Directed Nuclease EditorTM (DNE)
technology enables the production of custom genome editing enzymes that
can insert, remove, modify, and regulate essentially any gene in
mammalian or plant cells. Precision BioSciences has already produced
custom endonucleases for partners and internal development that can
precisely alter naturally occurring sequences within genomes. Precision
has partnered its DNE technology with several of the world’s largest
agbiotech firms and is internally developing applications in biological
production and human therapeutics. For additional information, please
visit www.precisionbiosciences.com.
|
